Allergan buys second fatty liver-disease company
 

Allergan buys second fatty liver-disease company
Sept 20 (Reuters) - Allergan Inc on Tuesday said ithad paid $50 million for Akarna Therapeutics Ltd, a privatelyheld company developing treatments for a incurable fatty liverdisease called NASH.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...r8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...r8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/s3sUTeQNQr0